Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD83 is a member of the C/D box snoRNA family, which are short, non-coding RNAs that guide sequence-specific 2′-O-ribose methylation of target RNAs—primarily ribosomal RNA—during ribosome biogenesis[2][3][4][5]. SNORD83 functions as a recognition scaffold inside nucleolar ribonucleoprotein complexes (snoRNPs), recruiting proteins such as fibrillarin, NOP56, NOP58, and SNU13 to catalyze methylation at specific sites in RNA[2][3][4][5]. It is highly conserved, localized to the nucleolus, and participates in the maturation and stabilization of ribosomes. SNORD83 is not a receptor, enzyme, or drug target, but its proper function is essential for cell viability and protein synthesis through its role in ribosomal RNA processing[2][4][5]. Direct associations with disease or use as a clinical biomarker are not described for SNORD83 as of current literature.
Not applicable. No drugs currently target SNORD83.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD83 (SNORD83).